Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing.
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infect
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infect
The University of Houston College of Pharmacy is included in a $68.5 million funding package from the Cancer Prevention and Research Institute of Texas (CPRIT).